Brief: Medicenna Therapeutics Reports Q3 Loss Per Share Of C$0.07
14/02/2019 22:29
Feb 14 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA REPORTS THIRD QUARTER FISCAL 2019 FINANCIAL
RESULTS
* Q3 LOSS PER SHARE C$0.07
Source text for Eikon: ID:nCNWmgN19a
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results